Back to dashboard
All PlansAdministrativeMedium impact

Recall: Sodium Bicarbonate

UPMC Health Plan·Emergency Medicine, Critical Care, Anesthesiology +2 more·Pharmacy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

Exela Pharma Sciences has recalled 49 lots of Sodium Bicarbonate Injection USP 8.4% due to safety concerns. Healthcare practices should immediately check inventory and stop using recalled lots of this medication used to treat acidosis.

Action Required

Action needed
Immediately: Clinical staff must check all inventory of Sodium Bicarbonate Injection USP 8.4% 50 mEq/50 mL vials from Exela Pharma Sciences and quarantine any recalled lots. Review the full recall notice at the provided URL to identify specific lot numbers. Contact pharmacy to arrange replacement stock from non-recalled suppliers.

Related policy hubs